Heart Tronics Stock

Heart Tronics ROCE

The Return on Capital Employed (ROCE) of Heart Tronics (HRTT) as of Jul 30, 2026 is -489.51 %.

ROCE

-489.51 %

Last updated:

In 2026, Heart Tronics's return on capital employed (ROCE) was -489.51 %, a % increase from the - ROCE in the previous year.

Access this data via the Eulerpool API

Heart Tronics Stock analysis

What does Heart Tronics do? Heart Tronics Inc. is a company specializing in the development of medical devices and technologies aimed at monitoring and treating heart diseases. It was founded in 2000 by Dr. A. Martin Gerdes and is headquartered in Irvine, California. The company's business model is based on the development, production, and sale of life-saving medical devices. They offer a wide range of diagnostic and monitoring devices that help doctors diagnose and treat heart diseases. One of their main focuses is the development of devices for monitoring heart rhythm disorders, including factors like blood pressure, pulse rate, and respiratory rate. They also develop devices for the treatment of heart diseases, such as electrophysiological (EP) ablation devices and implantable cardioverter-defibrillators (ICD). Additionally, they have developed telemedicine products for remote patient monitoring, allowing doctors to monitor and analyze patient data in real time. Overall, Heart Tronics has developed a variety of products that have proven effective in the medical community and are focused on saving lives by helping doctors detect diseases and take preventive measures. The company is well positioned for future growth due to advancements in telemedicine and medical devices. They plan to expand their portfolio to develop even more life-saving technologies in the future. In conclusion, Heart Tronics is a company driven by the clear goal of saving lives. They have established themselves as pioneers in the development of medical devices for the treatment of heart diseases and are committed to continuously developing innovative technologies to improve people's lives. Heart Tronics is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Heart Tronics's Return on Capital Employed (ROCE)

Heart Tronics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Heart Tronics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Heart Tronics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Heart Tronics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Heart Tronics stock

Return on Capital Employed (ROCE) of Heart Tronics is -489.51 % in 2026.

Access this data via the Eulerpool API

Profitability — Heart Tronics

All Key Metrics — Heart Tronics